What is Myotonic Dystrophy Foundation?
Founded in 2007 and headquartered in San Francisco, the Myotonic Dystrophy Foundation operates as a global leader in patient-centric research and support. The organization serves as a vital nexus for individuals living with myotonic dystrophy, providing a comprehensive framework that integrates education, advocacy, and outreach. By maintaining a dual focus on immediate care and long-term curative research, the foundation has established itself as an authoritative voice in the biotechnology and medical research sectors, effectively mobilizing resources to address the unmet needs of the DM community.
How much funding has Myotonic Dystrophy Foundation raised?
Myotonic Dystrophy Foundation has raised a total of $82K across 1 funding round:
Debt
$82K
Debt (2021): $82K with participation from PPP
Key Investors in Myotonic Dystrophy Foundation
PPP
Public-Private Partnership
What's next for Myotonic Dystrophy Foundation?
With the infusion of this recent capital, the Myotonic Dystrophy Foundation is set to scale its research efforts and expand its global outreach programs. The strategic deployment of these funds will likely focus on enhancing clinical trial readiness and fostering collaborative partnerships with pharmaceutical innovators. As the organization moves through this growth phase, the emphasis remains on translating scientific discovery into tangible patient outcomes, ensuring that the foundation remains at the forefront of the global effort to eradicate myotonic dystrophy through sustained investment and rigorous advocacy.
See full Myotonic Dystrophy Foundation company page
